Low-Grade Glioma: Correlation of Short Echo Time ¹H-MR Spectroscopy with ²³Na MR Imaging

References

1. ↵
   Macdonald DR. Low-grade gliomas, mixed gliomas, and oligodendrogliomas. Semin Oncol 1994;21:236–48

   PubMedWeb of Science
2. ↵
   Cavaliere R, Lopes MB, Schiff D. Low-grade gliomas: an update on pathology and therapy. Lancet Neurol 2005;4:760–70

   CrossRefPubMedWeb of Science
3. ↵
   Perry A. Pathology of low-grade gliomas: an update of emerging concepts. Neuro-oncol 2003;5:168–78

   Abstract/FREE Full Text
4. ↵
   Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:2076–84

   Abstract/FREE Full Text
5. ↵
   Stege EM, Kros JM, de Bruin HG, et al. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine. Cancer 2005;103:802–09

   CrossRefPubMedWeb of Science
6. ↵
   Isobe T, Matsumura A, Anno I, et al. Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 2002;20:343–49

   CrossRefPubMed
7. ↵
   Tong Z, Yamaki T, Harada K, et al. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. Magn Reson Imaging 2004;22:1017–24

   CrossRefPubMedWeb of Science
8. ↵
   Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003;49:223–32

   CrossRefPubMed
9. ↵
   Nelson SJ, Graves E, Pirzkall A, et al. In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imaging 2002;16:464–76

   CrossRefPubMed
10. ↵
    Li X, Jin H, Lu Y, et al. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed 2004;17:10–20

    CrossRefPubMed
11. ↵
    Takano T, Lin JH, Arcuino G, et al. Glutamate release promotes growth of malignant gliomas. Nat Med 2001;7:1010–15

    CrossRefPubMedWeb of Science
12. ↵
    Rijpkema M, Schuuring J, van der Meulen Y, et al. Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging. NMR Biomed 2003;16:12–18

    CrossRefPubMedWeb of Science
13. ↵
    Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000;21:1645–49

    Abstract/FREE Full Text
14. ↵
    Turski PA, Houston LW, Perman WH, et al. Experimental and human brain neoplasms: detection with in vivo sodium MR imaging. Radiology 1987;163:245–49

    PubMed
15. ↵
    Ouwerkerk R, Bleich KB, Gillen JS, et al. Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 2003;227:529–37

    PubMedWeb of Science
16. ↵
    Schepkin VD, Ross BD, Chenevert TL, et al. Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma. Magn Reson Med 2004;53:85–92
17. Winkler SS. Sodium-23 magnetic resonance brain imaging. Neuroradiology 1990;32:416–20

    CrossRefPubMed
18. ↵
    Thulborn KR, Davis D, Adams H, et al. Quantitative tissue sodium concentration mapping of the growth of focal cerebral tumors with sodium magnetic resonance imaging. Magn Reson Med 1999;41:351–59

    CrossRefPubMedWeb of Science
19. ↵
    Kassem MN, Bartha R. Quantitative proton short-echo-time LASER spectroscopy of normal human white matter and hippocampus at 4 Tesla incorporating macromolecule subtraction. Magn Reson Med 2003;49:918–27

    CrossRefPubMedWeb of Science
20. ↵
    Garwood M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J Magn Reson 2001;153:155–77

    CrossRefPubMedWeb of Science
21. ↵
    Tkac I, Starcuk Z, Choi IY, et al. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 1999;41:649–56

    CrossRefPubMedWeb of Science
22. ↵
    Bartha R, Menon RS. Long component time constant of 23Na T*2 relaxation in healthy human brain. Magn Reson Med 2004;52:407–10

    CrossRefPubMed
23. ↵
    Parrish TB, Fieno DS, Fitzgerald SW, et al. Theoretical basis for sodium and potassium MRI of the human heart at 1.5 T. Magn Reson Med 1997;38:653–61

    PubMed
24. ↵
    Boada FE, Shen GX, Chang SY, et al. Spectrally weighted twisted projection imaging: reducing T2 signal attenuation effects in fast three-dimensional sodium imaging. Magn Reson Med 1997;38:1022–28

    PubMed
25. ↵
    Boada FE, Gillen JS, Shen GX, et al. Fast three dimensional sodium imaging. Magn Reson Med 1997;37:706–15

    PubMedWeb of Science
26. ↵
    Bartha R, Drost DJ, Menon RS, et al. Spectroscopic lineshape correction by QUECC: combined QUALITY deconvolution and eddy current correction. Magn Reson Med 2000;44:641–45

    CrossRefPubMed
27. ↵
    Bartha R, Drost DJ, Williamson PC. Factors affecting the quantification of short echo in-vivo 1H MR spectra: prior knowledge, peak elimination, and filtering. NMR Biomed 1999;12:205–16

    CrossRefPubMedWeb of Science
28. ↵
    Stanley JA, Drost DJ, Williamson PC, et al. The use of a priori knowledge to quantify short echo in vivo 1H MR spectra. Magn Reson Med 1995;34:17–24

    PubMedWeb of Science
29. ↵
    Ashburner J, Friston K. Multimodal image coregistration and partitioning–a unified framework. Neuroimage 1997;6:209–17

    CrossRefPubMedWeb of Science
30. ↵
    Bartha R, Michaeli S, Merkle H, et al. In vivo 1H2O T2+ measurement in the human occipital lobe at 4T and 7T by Carr-Purcell MRI: detection of microscopic susceptibility contrast. Magn Reson Med 2002;47:742–50

    CrossRefPubMed
31. Mason GF, Chu WJ, Hetherington HP. A general approach to error estimation and optimized experiment design, applied to multislice imaging of T1 in human brain at 4.1 T. J Magn Reson 1997;126:18–29

    CrossRefPubMed
32. Posse S, Cuenod CA, Risinger R, et al. Anomalous transverse relaxation in 1H spectroscopy in human brain at 4 Tesla. Magn Reson Med 1995;33:246–52

    CrossRefPubMed
33. ↵
    Michaeli S, Garwood M, Zhu XH, et al. Proton T2 relaxation study of water, N-acetylaspartate, and creatine in human brain using Hahn and Carr-Purcell spin echoes at 4T and 7T. Magn Reson Med 2002;47:629–33

    CrossRefPubMed
34. ↵
    Usenius JP, Vainio P, Hernesniemi J, et al. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994;63:1538–43

    PubMedWeb of Science
35. Matsumura A, Isobe T, Anno I, et al. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study. J Clin Neurosci 2005;12:416–20

    CrossRefPubMed
36. ↵
    Manton DJ, Lowry M, Blackband SJ, et al. Determination of proton metabolite concentrations and relaxation parameters in normal human brain and intracranial tumours. NMR Biomed 1995;8:104–12

    PubMedWeb of Science
37. ↵
    Block W, Traber F, Flacke S, et al. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 2002;23:317–23

    CrossRefPubMedWeb of Science
38. ↵
    Bartha R. Effect of signal-to-noise ratio and spectral linewidth on metabolite quantification at 4 T. NMR Biomed 2007;20:512–21

    CrossRefPubMedWeb of Science
39. ↵
    Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989–98

    Abstract/FREE Full Text
40. ↵
    Whittall KP, MacKay AL, Graeb DA, et al. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med 1997;37:34–43

    CrossRefPubMedWeb of Science